Vaughan R. Leydon

Statistics

Publications

Citations

796

H-Index

Active since

2005

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Vaughan R. Leydon is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, topoisomerase activity, and quinolone resistance mechanisms.

Publications per year

2005–2020

Publications

Crystal Structure of Human Cytochrome P450 2D6

Paul Rowland, Frank E. Blaney, Martin G. Smyth et al. · Journal of Biological Chemistry · 2005 · 435 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance

Alexandre Wohlkönig, Pan F. Chan, Andrew Fosberry et al. · Nature Structural & Molecular Biology · 2010 · 305 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Development of a novel mammalian display system for selection of antibodies against membrane proteins

N.J. Robertson, Nancy López-Antón, Shalom A. Gurjar et al. · Journal of Biological Chemistry · 2020 · 31 citations · Full text

Pharmacy, Biochemistry, Biotechnology +17

Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol 17(9): 1152-1153

Alexandre Wohlkönig, Pan F. Chan, Andrew Fosberry et al. · 2010 · 25 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

1–4 of 4